MedTrace Logo

A Prospective Cohort Study of China Serum Uric Acid Levels

NCT03616769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3535

Last updated 2021-03-24

No results posted yet for this study

Summary

Uric acid is the final breakdown product of purine degradation in humans. The association between high serum uric acid levels and arterial stiffness as well as endothelial dysfunction has been demonstrated in humans and uric acid has been suggested to be an important modulator of the inflammatory process. But debates still existed for hyperuricemia and hypouricemia as an independent role,especially after controlling other traditional atherosclerotic risk.The aim of this study was, firstly, to verify the association between hyperuricemia and cardiovascular diseases,secondly,to assess whether hypouricemia was an independent risk factor impact for cardiovascular disea.

Conditions

  • Uric Acid Serum

Interventions

DRUG

antiplatelet drugs ,statins ,antihypertensive drugs

According to the international guidelines, we treated patients who suffered from different disease.

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-20
Primary Completion
2013-03-12
Completion
2018-06-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03616769 on ClinicalTrials.gov